Washington, DC — A new coalition of drug infusion providers has been established to advocate for policies that preserve patients’ access to infused medicines in the convenient and cost-efficient in-office and freestanding ambulatory facility settings. The Infusion Providers Alliance (IPA), will be the leading voice for providers of drug infusion services in this outpatient setting of care and will lead an effort to preserve the integrity of the doctor-patient relationship in a manner that delivers exceptional care to patients at a lower cost to the health care system. The IPA represents infusion providers with over 750 locations in more than 40 states across the U.S. Collectively, the IPA members administer more than 500,000 treatments annually.
IPA Letter on “New Requirement to Obtain Certain Drugs from CVS Specialty Pharmacy”
READ LETTER HERE: IPA Letter to Anthem